Sağlam Zehra Güven, Yildirim Mustafa, Laloğlu Esra
Deparment of Ophthalmolgy, Ağrı Education and Research Hospital, Ağrı, Turkey.
Department of Ophthalmology, School of Medicine, Ataturk University, Erzurum, 25240, Turkey.
Graefes Arch Clin Exp Ophthalmol. 2025 Jul 14. doi: 10.1007/s00417-025-06910-w.
This study aimed to compare the levels of procollagen C proteinase-enhancing protein 1 and Procollagen C Proteinase Enhancing Protein 2 (PCPE-1/PCPE-2) in the serum of patients with keratoconus and healthy individuals, and to evaluate their potential effects on keratoconus.
This study prospectively included 65 patients diagnosed with keratoconus and followed up between October 2023 and May 2024, and 65 healthy individuals. 65 patients diagnosed with keratoconus were examined in the four groups. Serum PCEP-1 and PCEP-2 levels were measured in venous blood samples from the patient and control groups using ELISA.
A total of 130 patients were included in the study and divided into two groups: patients (n = 65) and controls (n = 65). The PCPE1 levels were 8.89 ± 4.45 (median: 7.38) in the patient group and 16.91 ± 11.30 (median: 13.18) in the control group, with a statistically significant difference (p = 0.001). In the patient group, PCPE2 levels were 10.32 ± 8.01 (median: 6.75), whereas in the control group, they were 19.62 ± 13.81 (median: 13.96), with this difference being statistically significant (p = 0.001). A significant positive correlation was observed between PCPE1 and PCPE2 expression in the patient group (r = 0.768, p = 0.001). Significant differences were detected between the stages in terms of PCPE1 (p = 0.001) and PCPE2 (p = 0.001) levels.
Serum PCPE-1 and PCPE-2 levels were significantly decreased in keratoconus and correlated with disease stage, indicating their potential as systemic biomarkers of collagen remodeling and disease progression.
What is known Keratoconus is an idiopathic, non-inflammatory, and progressive ectatic disease characterized by an irregular conical shape and thinning of the central and peripheral parts of the cornea. The extracellular matrix (ECM) of the cornea is particularly rich in collagen, and the synthesis of these components follows a specific program during corneal development and maturation. What is new PCPE-1 plays an important role in collagen fibril formation and tissue repair. PCPE-2 has a strong collagen-binding capacity and is highly expressed in developmental tissues and the adult heart. Dysfunction in the balance of corneal collagen synthesis and extracellular matrix formation in keratoconus indicates that these molecules may play an active role in corneal pathology.
本研究旨在比较圆锥角膜患者与健康个体血清中前胶原C蛋白酶增强蛋白1和前胶原C蛋白酶增强蛋白2(PCPE-1/PCPE-2)的水平,并评估它们对圆锥角膜的潜在影响。
本研究前瞻性纳入了2023年10月至2024年5月期间诊断为圆锥角膜并接受随访的65例患者以及65名健康个体。将65例诊断为圆锥角膜的患者分为四组进行检查。采用酶联免疫吸附测定法(ELISA)检测患者组和对照组静脉血样本中的血清PCEP-1和PCEP-2水平。
本研究共纳入130例患者,分为两组:患者组(n = 65)和对照组(n = 65)。患者组PCPE1水平为8.89±4.45(中位数:7.38),对照组为16.91±11.30(中位数:13.18),差异具有统计学意义(p = 0.001)。患者组PCPE2水平为10.32±8.01(中位数:6.75),对照组为19.62±13.81(中位数:13.96),差异具有统计学意义(p = 0.001)。患者组中PCPE1与PCPE2表达之间存在显著正相关(r = 0.768,p = 0.001)。在PCPE1(p = 0.001)和PCPE2(p = 0.001)水平方面,各阶段之间存在显著差异。
圆锥角膜患者血清中PCPE-1和PCPE-2水平显著降低,且与疾病阶段相关,表明它们作为胶原重塑和疾病进展的全身生物标志物的潜力。
已知情况圆锥角膜是一种特发性、非炎症性、进行性扩张性疾病,其特征为角膜中央和周边部分呈不规则圆锥形且变薄。角膜的细胞外基质(ECM)富含胶原蛋白,这些成分的合成在角膜发育和成熟过程中遵循特定程序。新发现PCPE-1在胶原纤维形成和组织修复中起重要作用。PCPE-2具有很强的胶原结合能力,在发育组织和成年心脏中高表达。圆锥角膜中角膜胶原合成与细胞外基质形成平衡的失调表明这些分子可能在角膜病理过程中起积极作用。